000 01502 a2200385 4500
005 20250515052458.0
264 0 _c20070405
008 200704s 0 0 eng d
022 _a0165-5728
024 7 _a10.1016/j.jneuroim.2006.11.027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaylor, Jude Matthew
245 0 0 _aSoluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation.
_h[electronic resource]
260 _bJournal of neuroimmunology
_cFeb 2007
300 _a118-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibodies
_xadministration & dosage
650 0 4 _aBlood-Brain Barrier
_xdrug effects
650 0 4 _aCapillary Permeability
_xdrug effects
650 0 4 _aDisease Models, Animal
650 0 4 _aEncephalomyelitis, Autoimmune, Experimental
_xchemically induced
650 0 4 _aFemale
650 0 4 _aInflammation
_xetiology
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMale
650 0 4 _aMyelin Sheath
_ximmunology
650 0 4 _aRats
650 0 4 _aRats, Inbred Lew
650 0 4 _aReceptors, Tumor Necrosis Factor, Type I
_xadministration & dosage
650 0 4 _aTime Factors
700 1 _aPollard, John David
773 0 _tJournal of neuroimmunology
_gvol. 183
_gno. 1-2
_gp. 118-24
856 4 0 _uhttps://doi.org/10.1016/j.jneuroim.2006.11.027
_zAvailable from publisher's website
999 _c16763467
_d16763467